Navigation Links
Weitlaner Retractor

ProductsWeitlaner Retractor
Company Codman
Item Weitlaner Retractor
Features 
Description Weitlaner retractor, blunt.
Info Codman
Customer Service: (800) 225-0460
Web site: http://www.codman.com

Related medicine products :

1. Baby Weitlaner Retractor
2. Beckman-Weitlaner Retractor
3. Weitlaner Beckmann Retractor
4. Sharp Weitlaner Retractor
5. Blunt Weitlaner Retractor
6. Weitlaner-Locktite retractors
7. Schuknecht-Weitlaner Retractor
8. Bloomberg Nucleus Rotator and Capsule Retractor
9. Stevenson Lacrimal Sac Retractor
10. Desmarres Lid Retractor
11. DesMarres Lid Retractor
ACRYSOF® Posterior Chamber Intraocular Lenses are indicated for the replacement of the human lens to achieve visual correction of aphakia in patients sixty years and older. These lenses are inten
Single-Piece PMMA Intraocular Lenses.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
STABIBAG Hydrophilic Acrylic Lens.
Medicine Products:
(Date:11/21/2008).../ -- Heska Corporation,(Nasdaq: HSKA ) today an...,Security Analysts, 12th Annual Biotech and Speci...7 Avenue of the Americas, 2nd Floor in New York, N... a.m. Eastern Time (7:35 a.m.,Mountain Time) and ...ks,following the presentation through a link unde...
(Date:11/21/2008)...Lennox-Gastaut syndrome , , FRIDAY, Nov....rufinamide) has been approved as a supplementary t...ox-Gastaut syndrome, the U.S. Food and Drug Admini...ased on results of a four-month clinical trial tha...ents who took a placebo, those who took the drug h...
(Date:11/21/2008)...enter.com, the premier site,for online nursing co...been,updated to improve the interactive experienc...ppincott Williams & Wilkins (LWW), NursingCent...uing education activities and free,access to 11,0...nals.,Lippincott Williams & Wilkins is a part...
(Date:11/21/2008)...tCall/ -- Today, prescription drugs are the first ...cent of patients suffering chronic conditions. Th...ndition account for 96 percent of all prescription.... A proprietary new pharmacy model developed over...: MHS ) significantly reduces critical gaps in c...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
...rma Awareness Month, and to commemorate the occasi...ng Out to Cure Scleroderma walks all share a commo...derma. "These events galvanize our patient commun...le of a little known but often debilitating diseas...
... dogs are more active and have less body fat than ...presented today at the 54th American College of Sp.... Dog ownership was associated with higher levels ...n the study, which examined differences in physica...
... were charged with corruption Friday for leaking q...d, in a scandal that cast a shadow over the countr... to be charged in connection with the affair, whic...mporary ban on the 17,000 nurses who had passed la...
...d a computerised decision analysis programme that ...on as it helps decide on the type of birth that i...veloped by a team of researchers led by Dr Montgom... of Bristol and Dundee. As part of the study, res...
Other Medicine News:Health News:Dog Owners More Active, Leaner 2Health News:Caesarean Births can Be Reduced by Computer Based Decision Analysis 2
(Date:11/19/2008)...wswire/ -- Posit Science Corporation,researcher, ...Neuroscience,Annual Conference in Washington, DC ...benefit Baby Boomers. The computerized brain plas...tive exercises that target auditory and,language ...ralized,improvements in cognition by improving sp...
(Date:11/19/2008)...hieve statistical significance , , ISELIN, ...orporation (Nasdaq: PARS ) today announced resul... NanoEmulsion (NE) drug delivery technology formul... The multi-center, randomized, double-blinded, pla...icacy of the Company,s 3% Diclofenac Diethanolamin...
(Date:11/19/2008)... Biotech scientists increasingly ar...earch to better understand the effects of novel dr...ts Genetic Engineering & Biotechnology News ...g out a new compound,s mechanism of action and eve...ue, according to the November 15 issue of GEN . (...
(Date:11/19/2008)... from Roche- , , MONTVALE, N.J., Nov. 19 /P...p. (Nasdaq: MEMY ) today announced that it has a...of R3487/MEM 3454, its lead alpha-7 nicotinic rece...ith schizophrenia (CIAS). The Company has randomi...a $5.0 million payment from its partner Roche. Me...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3CLRS Technology Accelerates Infrastructure Growth Anticipating FDA Clearance for At Home IPL Acne Device 20364 1CLRS Technology Accelerates Infrastructure Growth Anticipating FDA Clearance for At Home IPL Acne Device 20364 2CLRS Technology Accelerates Infrastructure Growth Anticipating FDA Clearance for At Home IPL Acne Device 20364 3Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 1Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 2Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 3Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 4Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 5Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 6Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 7Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 8Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 9Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 10Study Showed ALIMTA 28R 29 28pemetrexed for injection 29 Improved Survival in Certain Types of Non Small Cell Lung Cancer 20361 11REMINDER 3A Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 5656 1REMINDER 3A Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 5656 2REMINDER 3A Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 5656 3REMINDER 3A Exelixis Will Webcast Its June 2 Investor and Analyst Briefing at ASCO 5656 4Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 1Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 2Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 3Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 4Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 5Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 6Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 7Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 8Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 9Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 10Human Genome Sciences Reports Progress With Late Stage Products and New Initiatives 2200 11